Maya F Ilowite1,2,3, Hasan Al-Sayegh1, Clement Ma1,2, Veronica Dussel1,4, Abby R Rosenberg5,6,7, Chris Feudtner8, Tammy I Kang9, Joanne Wolfe1,2,3, Kira Bona1,2,3. 1. Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. 2. Harvard Medical School, Boston, Massachusetts. 3. Division of Population Sciences' Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts. 4. Center for Research and Implementation in Palliative Care, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina. 5. Seattle Children's Hospital Cancer and Blood Disorders Center, Seattle, Washington. 6. Department of Pediatrics, University of Washington, Seattle, Washington. 7. Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, Washington. 8. The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 9. Section of Palliative Care, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND: Children with advanced cancer experience high symptom distress, which negatively impacts their health-related quality of life (HRQOL). To the authors' knowledge, the relationship between income and symptom distress and HRQOL is not well described. METHODS: The Pediatric Quality of Life and Symptoms Technology (PediQUEST) multisite clinical trial evaluated an electronic patient-reported outcome system to describe symptom distress and HRQOL in children with advanced cancer via repeated surveys. The authors performed a secondary analysis of PediQUEST data for those children with available parent-reported household income (dichotomized at 200% of the Federal Poverty Level and categorized as low income [<$50,000/year] or high income [≥$50,000/year]). The prevalence of the 5 most commonly reported physical and psychological symptoms was compared between groups. Multivariable generalized estimating equation models were used to test the association between household income and symptom distress and HRQOL. RESULTS: A total of 78 children were included in the analyses: 56 (72%) in the high-income group and 22 (28%) in the low-income group. Low-income children were more likely to report pain than high-income children (64% vs 42%; P=.02). In multivariable models, children from low-income families demonstrated a uniform trend toward higher total (βlow-high =3.1; 95% confidence interval [95% CI], -0.08 to 6.2 [P=.06]), physical (β=3.8; 95% CI, -0.4 to 8.0 [P=.09]), and psychological (β=3.46; 95% CI, -1.91 to 8.84 [P=.21]) symptom distress compared with children from high-income families. Low income was associated with a uniform trend toward lower total (β=-7.9; 95% CI, -14.8, to -1.1 [P=.03]), physical (β=-11.2; 95% CI, -21.2 to -1.2 [P=.04]), emotional (β=-5.8; 95% CI, -13.6 to 2.0 [P=.15]), social (β=-2.52; 95% CI, -9.27 to 4.24 [P=.47]), and school (β=-9.8; 95% CI, -17.8 to -1.8 [P=.03]) HRQOL. CONCLUSIONS: In this cohort of children with advanced cancer, children from low-income families were found to experience higher symptom burden and worse QOL.
BACKGROUND:Children with advanced cancer experience high symptom distress, which negatively impacts their health-related quality of life (HRQOL). To the authors' knowledge, the relationship between income and symptom distress and HRQOL is not well described. METHODS: The Pediatric Quality of Life and Symptoms Technology (PediQUEST) multisite clinical trial evaluated an electronic patient-reported outcome system to describe symptom distress and HRQOL in children with advanced cancer via repeated surveys. The authors performed a secondary analysis of PediQUEST data for those children with available parent-reported household income (dichotomized at 200% of the Federal Poverty Level and categorized as low income [<$50,000/year] or high income [≥$50,000/year]). The prevalence of the 5 most commonly reported physical and psychological symptoms was compared between groups. Multivariable generalized estimating equation models were used to test the association between household income and symptom distress and HRQOL. RESULTS: A total of 78 children were included in the analyses: 56 (72%) in the high-income group and 22 (28%) in the low-income group. Low-income children were more likely to report pain than high-income children (64% vs 42%; P=.02). In multivariable models, children from low-income families demonstrated a uniform trend toward higher total (βlow-high =3.1; 95% confidence interval [95% CI], -0.08 to 6.2 [P=.06]), physical (β=3.8; 95% CI, -0.4 to 8.0 [P=.09]), and psychological (β=3.46; 95% CI, -1.91 to 8.84 [P=.21]) symptom distress compared with children from high-income families. Low income was associated with a uniform trend toward lower total (β=-7.9; 95% CI, -14.8, to -1.1 [P=.03]), physical (β=-11.2; 95% CI, -21.2 to -1.2 [P=.04]), emotional (β=-5.8; 95% CI, -13.6 to 2.0 [P=.15]), social (β=-2.52; 95% CI, -9.27 to 4.24 [P=.47]), and school (β=-9.8; 95% CI, -17.8 to -1.8 [P=.03]) HRQOL. CONCLUSIONS: In this cohort of children with advanced cancer, children from low-income families were found to experience higher symptom burden and worse QOL.
Keywords:
Pediatric Quality of Life and Symptoms Technology (PediQUEST); disparity in symptom burden; patient-reported outcomes; pediatric advanced cancer; pediatric palliative care
Authors: Lillian Sung; Rochelle Yanofsky; Robert J Klaassen; David Dix; Sheila Pritchard; Naomi Winick; Sarah Alexander; Anne Klassen Journal: Int J Cancer Date: 2011-03-01 Impact factor: 7.396
Authors: Madeleine S Didsbury; Siah Kim; Meredith M Medway; Allison Tong; Steven J McTaggart; Amanda M Walker; Sarah White; Fiona E Mackie; Tonya Kara; Jonathan C Craig; Germaine Wong Journal: J Paediatr Child Health Date: 2016-12 Impact factor: 1.954
Authors: Michael Joynt; Meghan K Train; Brett W Robbins; Jill S Halterman; Enrico Caiola; Robert J Fortuna Journal: J Gen Intern Med Date: 2013-12 Impact factor: 5.128
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Jamie R Wood; Kellee M Miller; David M Maahs; Roy W Beck; Linda A DiMeglio; Ingrid M Libman; Maryanne Quinn; William V Tamborlane; Stephanie E Woerner Journal: Diabetes Care Date: 2013-01-22 Impact factor: 19.112
Authors: Jennifer W Mack; Hajime Uno; Clare J Twist; Rochelle Bagatell; Abby R Rosenberg; Araz Marachelian; M Meaghan Granger; Julia Glade Bender; Justin N Baker; Julie R Park; Susan L Cohn; Jorge H Fernandez; Lisa R Diller; Suzanne Shusterman Journal: J Pain Symptom Manage Date: 2020-04-30 Impact factor: 3.612
Authors: Matthew Asare; Scott McIntosh; Eva Culakova; Amina Alio; M Renee Umstattd Meyer; Amber S Kleckner; Georges Adunlin; Ian R Kleckner; Kelly R Ylitalo; Charles S Kamen Journal: Int Q Community Health Educ Date: 2019-06-26
Authors: Liza-Marie Johnson; Erica C Kaye; Kimberly Sawyer; Alex M Brenner; Stefan J Friedrichsdorf; Abby R Rosenberg; Armand H Matheny Antommaria Journal: Pediatrics Date: 2021-01-14 Impact factor: 7.124
Authors: Jackelyn Y Boyden; Douglas L Hill; Russell T Nye; Kira Bona; Emily E Johnston; Pamela Hinds; Sarah Friebert; Tammy I Kang; Ross Hays; Matt Hall; Joanne Wolfe; Chris Feudtner Journal: J Pain Symptom Manage Date: 2021-08-20 Impact factor: 3.612
Authors: Puja J Umaretiya; Anna Revette; Anna Seo; Yael Flamand; Lenka Ilcisin; Daniel J Zheng; Smita Bhatia; Joanne Wolfe; Kira Bona Journal: Pediatr Blood Cancer Date: 2021-06-30 Impact factor: 3.838